Skip to main content
. 2022 Jun 9;9:870269. doi: 10.3389/fmed.2022.870269

Table 1.

The pattern of mutation and clinical symptoms in FV deficiency family.

Genotype Patient 1 Patient 2 Father Mother
Exon 3 Asp68His Heterozygote gac → cac Heterozygote Heterozygote Heterozygote
Exon 8 Met385Thr Heterozygote atg → acg Heterozygote Heterozygote Heterozygote
Exon13 Asn789Thr Heterozygote aac → acc Heterozygote Heterozygote Heterozygote
Exon13 Lys830Arg Heterozygote aaa → aga Heterozygote Heterozygote Heterozygote
Exon13 His837Arg Heterozygote cat → cgt Heterozygote Heterozygote Heterozygote
Exon13 Lys897Glu Heterozygote aag → gag Heterozygote Heterozygote Heterozygote
Exon16 Met1736Val Homozygote atg → gtg Homozygote Homozygote Heterozygote Heterozygote
Exon25 Asp2194Gly Heterozygote gat → ggt heterozygote Heterozygote
Clinical presentation
Age 19 20 51 44
Clinical symptoms Easy bruising 1. Easy bruising 2. Postpartum hemorrhage No bleeding episode No bleeding episode
Factor V activity, % (50–150%) 3.2% 2% 58% 54%
PT: sec (range: 8–12) 22.2 13.7 10.2 10.4
APTT: sec (range: 25.0–31.3) 53.2 33.8 30.5 31.0

Patient 1 and 2 both had the same clinical symptoms and the Factor V activity.

PT, Prothrombin time; APTT, Activated partial thromboplastin time.